Click for best price
Oral Hypoglycemic Drugs Market Size, Share 2022
Market Analysis and Insights: Global Oral Hypoglycemic Drugs Market
The global Oral Hypoglycemic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Hypoglycemic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Hypoglycemic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Hypoglycemic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Hypoglycemic Drugs market.
Global Oral Hypoglycemic Drugs Scope and Market Size
Oral Hypoglycemic Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Oral Hypoglycemic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Sulfonylureas (SU)
Double Guanidine
Glucosidase Inhibitor
Insulin Synergist
Segment by Application
Hospital
Clinic
Others
By Company
Pfizer
AstraZeneca
Johnson & Johnson
GlaxoSmithKline
Merck & Co
Eli Lilly
Sanofi
Takeda Pharmaceuticals
Novo Nordisk
Servier Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Oral Hypoglycemic Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Oral Hypoglycemic Drugs, with price, sales, revenue, and global market share of Oral Hypoglycemic Drugs from 2019 to 2022.
Chapter 3, the Oral Hypoglycemic Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Hypoglycemic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Oral Hypoglycemic Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Hypoglycemic Drugs.
Chapter 13, 14, and 15, to describe Oral Hypoglycemic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Oral Hypoglycemic Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Oral Hypoglycemic Drugs Market Insights and Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
109 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Oral Hypoglycemic Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Oral Hypoglycemic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sulfonylureas (SU)
1.2.3 Double Guanidine
1.2.4 Glucosidase Inhibitor
1.2.5 Insulin Synergist
1.3 Market by Application
1.3.1 Global Oral Hypoglycemic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Hypoglycemic Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Hypoglycemic Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Hypoglycemic Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Hypoglycemic Drugs Sales by Region
2.4.1 Global Oral Hypoglycemic Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Oral Hypoglycemic Drugs by Region (2023-2028)
2.5 Global Oral Hypoglycemic Drugs Revenue by Region
2.5.1 Global Oral Hypoglycemic Drugs Revenue by Region (2017-2022)
2.5.2 Global Oral Hypoglycemic Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Hypoglycemic Drugs Sales by Manufacturers
3.1.1 Global Top Oral Hypoglycemic Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Hypoglycemic Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Hypoglycemic Drugs in 2021
3.2 Global Oral Hypoglycemic Drugs Revenue by Manufacturers
3.2.1 Global Oral Hypoglycemic Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Hypoglycemic Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Hypoglycemic Drugs Revenue in 2021
3.3 Global Oral Hypoglycemic Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Hypoglycemic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Hypoglycemic Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Hypoglycemic Drugs Sales by Type
4.1.1 Global Oral Hypoglycemic Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Oral Hypoglycemic Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
4.2 Global Oral Hypoglycemic Drugs Revenue by Type
4.2.1 Global Oral Hypoglycemic Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Hypoglycemic Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Oral Hypoglycemic Drugs Price by Type
4.3.1 Global Oral Hypoglycemic Drugs Price by Type (2017-2022)
4.3.2 Global Oral Hypoglycemic Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral Hypoglycemic Drugs Sales by Application
5.1.1 Global Oral Hypoglycemic Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Oral Hypoglycemic Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
5.2 Global Oral Hypoglycemic Drugs Revenue by Application
5.2.1 Global Oral Hypoglycemic Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Hypoglycemic Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Oral Hypoglycemic Drugs Price by Application
5.3.1 Global Oral Hypoglycemic Drugs Price by Application (2017-2022)
5.3.2 Global Oral Hypoglycemic Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Hypoglycemic Drugs Market Size by Type
6.1.1 North America Oral Hypoglycemic Drugs Sales by Type (2017-2028)
6.1.2 North America Oral Hypoglycemic Drugs Revenue by Type (2017-2028)
6.2 North America Oral Hypoglycemic Drugs Market Size by Application
6.2.1 North America Oral Hypoglycemic Drugs Sales by Application (2017-2028)
6.2.2 North America Oral Hypoglycemic Drugs Revenue by Application (2017-2028)
6.3 North America Oral Hypoglycemic Drugs Market Size by Country
6.3.1 North America Oral Hypoglycemic Drugs Sales by Country (2017-2028)
6.3.2 North America Oral Hypoglycemic Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oral Hypoglycemic Drugs Market Size by Type
7.1.1 Europe Oral Hypoglycemic Drugs Sales by Type (2017-2028)
7.1.2 Europe Oral Hypoglycemic Drugs Revenue by Type (2017-2028)
7.2 Europe Oral Hypoglycemic Drugs Market Size by Application
7.2.1 Europe Oral Hypoglycemic Drugs Sales by Application (2017-2028)
7.2.2 Europe Oral Hypoglycemic Drugs Revenue by Application (2017-2028)
7.3 Europe Oral Hypoglycemic Drugs Market Size by Country
7.3.1 Europe Oral Hypoglycemic Drugs Sales by Country (2017-2028)
7.3.2 Europe Oral Hypoglycemic Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Hypoglycemic Drugs Market Size by Type
8.1.1 Asia Pacific Oral Hypoglycemic Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Hypoglycemic Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Hypoglycemic Drugs Market Size by Application
8.2.1 Asia Pacific Oral Hypoglycemic Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Hypoglycemic Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Hypoglycemic Drugs Market Size by Region
8.3.1 Asia Pacific Oral Hypoglycemic Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Hypoglycemic Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oral Hypoglycemic Drugs Market Size by Type
9.1.1 Latin America Oral Hypoglycemic Drugs Sales by Type (2017-2028)
9.1.2 Latin America Oral Hypoglycemic Drugs Revenue by Type (2017-2028)
9.2 Latin America Oral Hypoglycemic Drugs Market Size by Application
9.2.1 Latin America Oral Hypoglycemic Drugs Sales by Application (2017-2028)
9.2.2 Latin America Oral Hypoglycemic Drugs Revenue by Application (2017-2028)
9.3 Latin America Oral Hypoglycemic Drugs Market Size by Country
9.3.1 Latin America Oral Hypoglycemic Drugs Sales by Country (2017-2028)
9.3.2 Latin America Oral Hypoglycemic Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Hypoglycemic Drugs Market Size by Type
10.1.1 Middle East and Africa Oral Hypoglycemic Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Hypoglycemic Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Hypoglycemic Drugs Market Size by Application
10.2.1 Middle East and Africa Oral Hypoglycemic Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Hypoglycemic Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Hypoglycemic Drugs Market Size by Country
10.3.1 Middle East and Africa Oral Hypoglycemic Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Hypoglycemic Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Johnson & Johnson Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GlaxoSmithKline Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 Merck & Co
11.5.1 Merck & Co Corporation Information
11.5.2 Merck & Co Overview
11.5.3 Merck & Co Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck & Co Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck & Co Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Corporation Information
11.6.2 Eli Lilly Overview
11.6.3 Eli Lilly Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Eli Lilly Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eli Lilly Recent Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sanofi Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Takeda Pharmaceuticals
11.8.1 Takeda Pharmaceuticals Corporation Information
11.8.2 Takeda Pharmaceuticals Overview
11.8.3 Takeda Pharmaceuticals Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Takeda Pharmaceuticals Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Takeda Pharmaceuticals Recent Developments
11.9 Novo Nordisk
11.9.1 Novo Nordisk Corporation Information
11.9.2 Novo Nordisk Overview
11.9.3 Novo Nordisk Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novo Nordisk Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novo Nordisk Recent Developments
11.10 Servier Laboratories
11.10.1 Servier Laboratories Corporation Information
11.10.2 Servier Laboratories Overview
11.10.3 Servier Laboratories Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Servier Laboratories Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Servier Laboratories Recent Developments
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Corporation Information
11.11.2 Boehringer Ingelheim Overview
11.11.3 Boehringer Ingelheim Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Boehringer Ingelheim Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Boehringer Ingelheim Recent Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Corporation Information
11.12.2 Bristol-Myers Squibb Overview
11.12.3 Bristol-Myers Squibb Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Bristol-Myers Squibb Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bristol-Myers Squibb Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Hypoglycemic Drugs Industry Chain Analysis
12.2 Oral Hypoglycemic Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Hypoglycemic Drugs Production Mode & Process
12.4 Oral Hypoglycemic Drugs Sales and Marketing
12.4.1 Oral Hypoglycemic Drugs Sales Channels
12.4.2 Oral Hypoglycemic Drugs Distributors
12.5 Oral Hypoglycemic Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Hypoglycemic Drugs Industry Trends
13.2 Oral Hypoglycemic Drugs Market Drivers
13.3 Oral Hypoglycemic Drugs Market Challenges
13.4 Oral Hypoglycemic Drugs Market Restraints
14 Key Findings in The Global Oral Hypoglycemic Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Oral Hypoglycemic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Sulfonylureas (SU)
Table 3. Major Manufacturers of Double Guanidine
Table 4. Major Manufacturers of Glucosidase Inhibitor
Table 5. Major Manufacturers of Insulin Synergist
Table 6. Global Oral Hypoglycemic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Oral Hypoglycemic Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Oral Hypoglycemic Drugs Sales by Region (2017-2022) & (K Units)
Table 9. Global Oral Hypoglycemic Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Oral Hypoglycemic Drugs Sales by Region (2023-2028) & (K Units)
Table 11. Global Oral Hypoglycemic Drugs Sales Market Share by Region (2023-2028)
Table 12. Global Oral Hypoglycemic Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Oral Hypoglycemic Drugs Revenue Market Share by Region (2017-2022)
Table 14. Global Oral Hypoglycemic Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Oral Hypoglycemic Drugs Revenue Market Share by Region (2023-2028)
Table 16. Global Oral Hypoglycemic Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Oral Hypoglycemic Drugs Sales Share by Manufacturers (2017-2022)
Table 18. Global Oral Hypoglycemic Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Oral Hypoglycemic Drugs Revenue Share by Manufacturers (2017-2022)
Table 20. Oral Hypoglycemic Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Oral Hypoglycemic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Oral Hypoglycemic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Hypoglycemic Drugs as of 2021)
Table 23. Oral Hypoglycemic Drugs Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Oral Hypoglycemic Drugs Product Offered
Table 25. Date of Manufacturers Enter into Oral Hypoglycemic Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oral Hypoglycemic Drugs Sales by Type (2017-2022) & (K Units)
Table 28. Global Oral Hypoglycemic Drugs Sales by Type (2023-2028) & (K Units)
Table 29. Global Oral Hypoglycemic Drugs Sales Share by Type (2017-2022)
Table 30. Global Oral Hypoglycemic Drugs Sales Share by Type (2023-2028)
Table 31. Global Oral Hypoglycemic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Oral Hypoglycemic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Oral Hypoglycemic Drugs Revenue Share by Type (2017-2022)
Table 34. Global Oral Hypoglycemic Drugs Revenue Share by Type (2023-2028)
Table 35. Oral Hypoglycemic Drugs Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Oral Hypoglycemic Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Oral Hypoglycemic Drugs Sales by Application (2017-2022) & (K Units)
Table 38. Global Oral Hypoglycemic Drugs Sales by Application (2023-2028) & (K Units)
Table 39. Global Oral Hypoglycemic Drugs Sales Share by Application (2017-2022)
Table 40. Global Oral Hypoglycemic Drugs Sales Share by Application (2023-2028)
Table 41. Global Oral Hypoglycemic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Oral Hypoglycemic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Oral Hypoglycemic Drugs Revenue Share by Application (2017-2022)
Table 44. Global Oral Hypoglycemic Drugs Revenue Share by Application (2023-2028)
Table 45. Oral Hypoglycemic Drugs Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Oral Hypoglycemic Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Oral Hypoglycemic Drugs Sales by Type (2017-2022) & (K Units)
Table 48. North America Oral Hypoglycemic Drugs Sales by Type (2023-2028) & (K Units)
Table 49. North America Oral Hypoglycemic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Oral Hypoglycemic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Oral Hypoglycemic Drugs Sales by Application (2017-2022) & (K Units)
Table 52. North America Oral Hypoglycemic Drugs Sales by Application (2023-2028) & (K Units)
Table 53. North America Oral Hypoglycemic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Oral Hypoglycemic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Oral Hypoglycemic Drugs Sales by Country (2017-2022) & (K Units)
Table 56. North America Oral Hypoglycemic Drugs Sales by Country (2023-2028) & (K Units)
Table 57. North America Oral Hypoglycemic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Oral Hypoglycemic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Oral Hypoglycemic Drugs Sales by Type (2017-2022) & (K Units)
Table 60. Europe Oral Hypoglycemic Drugs Sales by Type (2023-2028) & (K Units)
Table 61. Europe Oral Hypoglycemic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Oral Hypoglycemic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Oral Hypoglycemic Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Europe Oral Hypoglycemic Drugs Sales by Application (2023-2028) & (K Units)
Table 65. Europe Oral Hypoglycemic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Oral Hypoglycemic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Oral Hypoglycemic Drugs Sales by Country (2017-2022) & (K Units)
Table 68. Europe Oral Hypoglycemic Drugs Sales by Country (2023-2028) & (K Units)
Table 69. Europe Oral Hypoglycemic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Oral Hypoglycemic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Oral Hypoglycemic Drugs Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Oral Hypoglycemic Drugs Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Oral Hypoglycemic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Oral Hypoglycemic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Oral Hypoglycemic Drugs Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Oral Hypoglycemic Drugs Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Oral Hypoglycemic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Oral Hypoglycemic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Oral Hypoglycemic Drugs Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Oral Hypoglycemic Drugs Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Oral Hypoglycemic Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Oral Hypoglycemic Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Oral Hypoglycemic Drugs Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Oral Hypoglycemic Drugs Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Oral Hypoglycemic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Oral Hypoglycemic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Oral Hypoglycemic Drugs Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Oral Hypoglycemic Drugs Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Oral Hypoglycemic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Oral Hypoglycemic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Oral Hypoglycemic Drugs Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Oral Hypoglycemic Drugs Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Oral Hypoglycemic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Oral Hypoglycemic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Oral Hypoglycemic Drugs Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Oral Hypoglycemic Drugs Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Oral Hypoglycemic Drugs Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Oral Hypoglycemic Drugs Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Oral Hypoglycemic Drugs Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Oral Hypoglycemic Drugs Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 107. Pfizer Corporation Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Pfizer Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. AstraZeneca Corporation Information
Table 113. AstraZeneca Description and Major Businesses
Table 114. AstraZeneca Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. AstraZeneca Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. AstraZeneca Recent Developments
Table 117. Johnson & Johnson Corporation Information
Table 118. Johnson & Johnson Description and Major Businesses
Table 119. Johnson & Johnson Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Johnson & Johnson Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Johnson & Johnson Recent Developments
Table 122. GlaxoSmithKline Corporation Information
Table 123. GlaxoSmithKline Description and Major Businesses
Table 124. GlaxoSmithKline Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. GlaxoSmithKline Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. GlaxoSmithKline Recent Developments
Table 127. Merck & Co Corporation Information
Table 128. Merck & Co Description and Major Businesses
Table 129. Merck & Co Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Merck & Co Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Merck & Co Recent Developments
Table 132. Eli Lilly Corporation Information
Table 133. Eli Lilly Description and Major Businesses
Table 134. Eli Lilly Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Eli Lilly Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Eli Lilly Recent Developments
Table 137. Sanofi Corporation Information
Table 138. Sanofi Description and Major Businesses
Table 139. Sanofi Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Sanofi Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Sanofi Recent Developments
Table 142. Takeda Pharmaceuticals Corporation Information
Table 143. Takeda Pharmaceuticals Description and Major Businesses
Table 144. Takeda Pharmaceuticals Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Takeda Pharmaceuticals Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Takeda Pharmaceuticals Recent Developments
Table 147. Novo Nordisk Corporation Information
Table 148. Novo Nordisk Description and Major Businesses
Table 149. Novo Nordisk Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Novo Nordisk Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Novo Nordisk Recent Developments
Table 152. Servier Laboratories Corporation Information
Table 153. Servier Laboratories Description and Major Businesses
Table 154. Servier Laboratories Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Servier Laboratories Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Servier Laboratories Recent Developments
Table 157. Boehringer Ingelheim Corporation Information
Table 158. Boehringer Ingelheim Description and Major Businesses
Table 159. Boehringer Ingelheim Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Boehringer Ingelheim Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Boehringer Ingelheim Recent Developments
Table 162. Bristol-Myers Squibb Corporation Information
Table 163. Bristol-Myers Squibb Description and Major Businesses
Table 164. Bristol-Myers Squibb Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Bristol-Myers Squibb Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Bristol-Myers Squibb Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Oral Hypoglycemic Drugs Distributors List
Table 170. Oral Hypoglycemic Drugs Customers List
Table 171. Oral Hypoglycemic Drugs Market Trends
Table 172. Oral Hypoglycemic Drugs Market Drivers
Table 173. Oral Hypoglycemic Drugs Market Challenges
Table 174. Oral Hypoglycemic Drugs Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Hypoglycemic Drugs Product Picture
Figure 3. Global Oral Hypoglycemic Drugs Market Share by Type in 2021 & 2028
Figure 3. Sulfonylureas (SU) Product Picture
Figure 4. Double Guanidine Product Picture
Figure 5. Glucosidase Inhibitor Product Picture
Figure 6. Insulin Synergist Product Picture
Figure 7. Global Oral Hypoglycemic Drugs Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Oral Hypoglycemic Drugs Report Years Considered
Figure 12. Global Oral Hypoglycemic Drugs Sales 2017-2028 (K Units)
Figure 13. Global Oral Hypoglycemic Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Oral Hypoglycemic Drugs Revenue 2017-2028 (US$ Million)
Figure 15. Global Oral Hypoglycemic Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Oral Hypoglycemic Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Oral Hypoglycemic Drugs Sales Market Share by Region (2023-2028)
Figure 18. North America Oral Hypoglycemic Drugs Sales YoY (2017-2028) & (K Units)
Figure 19. North America Oral Hypoglycemic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Oral Hypoglycemic Drugs Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Oral Hypoglycemic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Oral Hypoglycemic Drugs Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Oral Hypoglycemic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Oral Hypoglycemic Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Oral Hypoglycemic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Oral Hypoglycemic Drugs Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Oral Hypoglycemic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Oral Hypoglycemic Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Oral Hypoglycemic Drugs in the World: Market Share by Oral Hypoglycemic Drugs Revenue in 2021
Figure 30. Global Oral Hypoglycemic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
Figure 35. North America Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
Figure 37. North America Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
Figure 39. North America Oral Hypoglycemic Drugs Sales Share by Country (2017-2028)
Figure 40. North America Oral Hypoglycemic Drugs Revenue Share by Country (2017-2028)
Figure 41. U.S. Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
Figure 45. Europe Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
Figure 46. Europe Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
Figure 47. Europe Oral Hypoglycemic Drugs Sales Share by Country (2017-2028)
Figure 48. Europe Oral Hypoglycemic Drugs Revenue Share by Country (2017-2028)
Figure 49. Germany Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. France Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Oral Hypoglycemic Drugs Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Oral Hypoglycemic Drugs Revenue Share by Region (2017-2028)
Figure 60. China Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. India Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
Figure 71. Latin America Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
Figure 73. Latin America Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Oral Hypoglycemic Drugs Sales Share by Country (2017-2028)
Figure 75. Latin America Oral Hypoglycemic Drugs Revenue Share by Country (2017-2028)
Figure 76. Mexico Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Oral Hypoglycemic Drugs Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Oral Hypoglycemic Drugs Revenue Share by Country (2017-2028)
Figure 85. Turkey Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
Figure 88. Oral Hypoglycemic Drugs Value Chain
Figure 89. Oral Hypoglycemic Drugs Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
